Drug Development Boot Camp

• Email
• Share
  • Digg
  • Facebook
  • LinkedIn

Cognigen CEO Ted Grasela will lecture on dose selection and justification using pharmacometrics at the Drug Development Boot Camp: An Intensive Two Day Course for Biotech and Pharma Company Executives.

Boot Camp will be held September 9 and 10, 2010, at Weill Cornell Medical College in New York City, and will be hosted by the Cornell Center for Technology Enterprise and Commercialization and Speid Associates, Inc.

The program will provide a unique opportunity to obtain hands-on insight into the drug development process from drug discovery (designation of a lead) to registration. For more information or to register for Boot Camp, go to http://www.drugstomarket.com/drugbootcamp/Register-and-Pay.html.